Suicidality and other severe psychiatric events with duloxetine: Re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia

MP Hengartner; M Plöderl

Suicidality and other severe psychiatric events with duloxetine: Re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia

Kalaidos School of Applied Psychology

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	209-218
Number of pages	10
Journal	International Journal of Risk and Safety in Medicine
Volume	32
Publication status	Published - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{44e3b6e4ccbb405d92eb3c65548be508,

title = "Suicidality and other severe psychiatric events with duloxetine: Re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia",

author = "MP Hengartner and M Pl{\"o}derl",

year = "2021",

language = "undefiniert/unbekannt",

volume = "32",

pages = "209--218",

journal = "International Journal of Risk and Safety in Medicine",

}

TY - JOUR

T1 - Suicidality and other severe psychiatric events with duloxetine: Re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia

AU - Hengartner, MP

AU - Plöderl, M

PY - 2021

Y1 - 2021

M3 - Artikel

VL - 32

SP - 209

EP - 218

JO - International Journal of Risk and Safety in Medicine

JF - International Journal of Risk and Safety in Medicine

ER -